Vitamin D and its implications for musculoskeletal health in women: An update

Maturitas

Volumn 58, Issue 2, 2007, Pages 117-137

  Pérez López, Faustino R ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Aging; Bisphosphonates; Fracture; Inadequate diet; Menopause; Musculoskeletal health; Neuromuscular function; Osteoarthritis; Osteopenia; Osteoporosis; Postmenopausal women; Secondary hyperparathyroidism; Sun exposure; Vitamin D; Vitamin D and falls; Vitamin D insufficiency

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

AGING; ARTICLE; BONE METABOLISM; DIET SUPPLEMENTATION; DIETARY INTAKE; FALLING; FOOD INTAKE; FRACTURE; HUMAN; INTESTINE ABSORPTION; KIDNEY; LIVER; MENOPAUSE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; NEUROMUSCULAR FUNCTION; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SKIN; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY;

CALCIUM, DIETARY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; OSTEOARTHRITIS; OSTEOPOROSIS, POSTMENOPAUSAL; VITAMIN D DEFICIENCY;

EID: 34848845797     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.05.002     Document Type: Article

References (153)

1. Osteoporosis Treatment Update 2006. http://www.osteofound.org/wco/2006/media_centre/20060603_treatment/20060603_treatment.doc [accesed July 22, 2006].
2. Pérez-López F.R. Vitamin D: the secosteroid hormone and human reproduction. Gynecol Endocrinol 23 (2007) 13-24
3. Javaid M.K., Crozier S.R., Harvey N.C., et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 367 (2006) 36-43 [Erratum in: Lancet 2006;367:1486]
4. Siqueira F.V., Facchini L.A., Reichert F.F., Azevedo M.R., Bastos J.P., and Hallal P.C. The role of adolescent physical activity on osteoporosis in later life. Abstracts of the IOF World Congress. Toronto, Canadá, June 2-6 (2006) S72 P260SU
5. Thijssen J.H. Gene polymorphisms involved in the regulation of bone quality. Gynecol Endocrinol 22 (2006) 131-139
6. Papadimitropoulos E., Wells G., Shea B., et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23 (2002) 560-569
7. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., and Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293 (2005) 2257-2264
8. Villareal D.T., Civitelli R., Chines A., and Avioli L.V. Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab 72 (1991) 628-634
9. Mezquita-Raya P., Muñoz-Torres M., Luna J.D., et al. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Mineral Res 16 (2001) 1408-1415
10. Díaz Curiel M., and Espinoza Pineda J. Fisiopatología de la osteoporosis. In: Castelo-Branco C., and Haya Palazuelos J. (Eds). Osteoporosis y menopausia (2004), Panamericana, Madrid 75-82
11. Becker C., Crow S., Toman J., et al. Characteristics of elderly patients admitted to an urban tertiary care hospital with osteoporotic fractures: correlations with risk factors, fracture type, gender and ethnicity. Osteoporos Int 17 (2006) 410-416
12. Herrera A., Martínez A.A., Ferrández L., Gil E., and Moreno A. Epidemiology of osteoporotic hip fractures in Spain. Int Orthop 30 (2006) 11-14
13. Glerup H., Mikkelsen K., Poulsen L., et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66 (2000) 419-424
14. Holick M.F. Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc 46 (1987) 1876-1882
15. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentration, and safety. Am J Clin Nutr 69 (1999) 842-856
16. Vantieghem K., Kissmeyer A.M., De Haes P., Bouillon R., and Segaert S. UVB-induced production of 1,25-dihydroxyvitamin D3 and vitamin D activity in human keratinocytes pretreated with a sterol Delta7-reductase inhibitor. J Cell Biochem 98 (2006) 81-92
17. De Haes P., Garmyn M., Verstuyf A., et al. 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B 78 (2005) 141-148
18. Jones G., Strugnell S.A., and DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol Rev 78 (1998) 1193-1231
19. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26 (2005) 662-687
20. Bronner F. Extracellular and intracellular regulation of calcium homeostasis. Sci World J 1 (2001) 919-925
21. Davey G.K., Spencer E.A., Appleby P.N., Allen N.E., Knox K.H., and Key T.J. Epic-Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33,883 meat-eaters and 31,546 non-meat-eaters in the United Kingdom. Public Health Nutr 6 (2003) 259-268
22. Michaëlsson K., Lithell H., Vessby B., and Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med 348 (2003) 287-294
23. Lips P. Hypervitaminosis A and fractures. N Engl J Med 348 (2003) 347-349
24. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
25. Suda T., Ueno Y., Fujii K., and Shinki T. Vitamin D and bone. J Cell Biochem 88 (2002) 259-266
26. 3 in thyroparathyroidectomized rats. Endocrinology 94 (1974) 1022-1027
27. Yamamoto M., Kawanobe Y., Takahashi H., Shimazawa E., Kimura S., and Ogata E. Vitamin D deficiency and renal calcium transport in the rat. J Clin Invest 74 (1984) 507-513
28. Sahota O., Mundey M.K., San P., Godber I.M., Lawson N., and Hosking D.J. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35 (2004) 312-319
29. Visser M., Deeg D.J., and Lips P. Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88 (2003) 5766-5772
30. Chapuy M.C., Preziosi P., Maamer M., et al. Prevalence of vitamin D insuficiency in an adult normal population. Osteoporos Int 7 (1997) 439-443
31. Malabanan A.O., and Holick M.F. Vitamin D and bone health in postmenopausal women. J Womens Health (Larchmt) 12 (2003) 151-156
32. Heaney R.P. Vitamin D: how much do we need, and how much is too much?. Osteoporosis Int 11 (2000) 553-555
33. Heaney R.P., Dowell D.S., Hale C.A., and Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22 (2003) 142-146
34. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., and Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84 (2006) 18-28
35. Reginster J.-Y., Frederick I., Deroisy R., et al. Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D levels increase with age in elderly women. Osteoporosis Int 8 (1998) 390-392
36. Maluche H.H., Koszewski N., Monier-Faugere M.C., Williams J.P., and Mawad H. Influence of the parathyroid glands on bone metabolism. Eur J Clin Invest 36 Suppl 2 (2006) 23-33
37. Khaw K.T., Sneyd M.J., and Compston J. Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 305 (1992) 273-277
38. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 (2001) 477-501
39. Lips P., Duong T., Oleksik A., et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86 (2001) 1212-1221
40. Feskanich D., Willett W.C., and Colditz G.A. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr 77 (2003) 504-511
41. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., and Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116 (2004) 634-639
42. Calvo M.S., and Whiting S.J. Public health strategies to overcome barriers to optimal vitamin D status in populations with special needs. J Nutr 136 (2006) 1135-1139
43. Zadshir A., Tareen N., Pan D., Norris K., and Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 15 4 Suppl 5 (2005) S5-97-S5-101
44. Bouillon R. Europeans deficient in vitamin D. http://www.upi.com/ConsumerHealthDaily/view.php?StoryID=20060402-052717-9887r [accessed July 24, 2006].
45. González-Clemente J.M., Martinez-Osaba M.J., Minarro A., Delgado M.P., Mauricio D., and Ribera F. Hypovitaminosis D: its high prevalence in elderly outpatients in Barcelona. Associated factors. Med Clin (Barc) 113 (1999) 641-645
46. Aguado P., Garcés M.V., González Casaus M.L., et al. High prevalence of vitamin D deficiency in postmenopausal women at a rheumatology office in Madrid. Evaluation of 2 vitamin D prescription regimens. Med Clin (Barc) 114 (2000) 326-330
47. Gómez Alonso C., Naves Díaz M., Rodríguez García M., Fernández Martín J.L., and Cannata Andía J.B. Review of the concept of vitamin D "sufficiency and insufficiency". Nefrología 23 Suppl 2 (2003) 73-77
48. Stamp T.C., and Round J.M. Seasonal changes in human plasma levels of 25 hydroxyvitamin D. Nature 247 (1974) 563-565
49. Benucci A., Tommasi M., Fantappie B., et al. Serum 25-hydroxyvitamin D levels in normal subjects: seasonal variations and relationships with parathyroid hormone and osteocalcin. J Nucl Biol Med 37 (1993) 77-82
50. Cugini P., Coen G., Scavo D., et al. Circannual versus seasonal variations of longitudinally sampled 25-hydroxycholecalciferol serum levels. Biochem Med 32 (1984) 22-29
51. Woitge H.W., Knothe A., Witte K., et al. Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res 15 (2000) 2443-2450 [comment in: J Bone Miner Res 2001;16:1733; author reply 1734]
52. Meier C., Woitge H.W., Witte K., Lemmer B., and Seibel M.J. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 19 (2004) 1221-1230
53. Pasco J.A., Henry M.J., Kotowicz M.A., et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 19 (2004) 752-758
54. Lucas J.A., Bolland M.J., Grey A.B., et al. Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int 16 (2005) 1641-1648
55. García-Pérez M.A., Moreno-Mercer J., Tarín J.J., and Cano A. Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women. Maturitas 45 (2003) 67-74
56. Quesada J.M., Coopmans W., Ruiz B., Aljama P., Jans I., and Bouillon R. Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 75 (1992) 494-501
57. Vieth R., Ladak Y., and Walfish P.G. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88 (2003) 185-191
58. Need A.G., O'Loughlin P.D., Morris H.A., Horowitz M., and Nordin B.E. The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab 89 (2004) 1646-1649
59. Clemens T.L., Zhou X.Y., Myles M., Endres D., and Lindsay R. Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab 63 (1986) 656-660
60. Pattanaungkul S., Riggs B.L., Yergey A.L., Vieira N.E., O'Fallon W.M., and Khosla S. Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 85 (2000) 4023-4027
61. Harris S.S. Vitamin D and African Americans. J Nutr 136 (2006) 1126-1129
62. Parisien M., Cosman F., Morgan D., et al. Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women. J Bone Miner Res 12 (1997) 948-957
63. Dawson-Hughes B., Harris S.S., Finneran S., and Rasmussen H.M. Calcium absorption responses to calcitriol in black and white premenopausal women. J Clin Endocrinol Metab 80 (1995) 3068-3072
64. Cosman F., Morgan D.C., Nieves J.W., et al. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res 12 (1997) 958-966
65. Diamond T.H., Levy S., Smith A., and Day P. High bone turnover in Muslim women with vitamin D deficiency. MJA 177 (2002) 139-141
66. Erkal M.Z., Wilde J., Bilgin Y., et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 17 (2006) 1133-1140
67. Allali F., El Aichaoui S., Saoud B., Maaroufi H., Abouqal R., and Hajjaj-Hassouni N. The impact of clothing style on bone mineral density among post menopausal women in Morocco: a case-control study. BMC Public Health 6 (2006) 135
68. Taha W., Chin D., Silverberg A.I., Lashiker L., Khateeb N., and Anhalt H. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn. Pediatrics 107 (2001) E79
69. Bell N.H., Epstein S., Greene A., Shary J., Oexmann M.J., and Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76 (1985) 370-373
70. Liel Y., Ulmer E., Shary J., Hollis B.W., and Bell N.H. Low circulating vitamin D in obesity. Calcif Tissue Int 43 (1988) 199-201
71. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
72. Arunabh S., Pollack S., Yeh J., and Aloia J.F. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88 (2003) 157-161
73. Snijder M.B., van Dam R.M., Visser M., et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90 (2005) 4119-4123
74. Yanoff L.B., Parikh S.J., Spitalnik A., et al. The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) 64 (2006) 523-529
75. Koutkia P., Lu Z., Chen T.C., and Holick M.F. Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology 121 (2001) 1485-1488
76. Lamb E.J., Wong T., Smith D.J., et al. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 16 (2002) 1895-1902
77. Hansen L.B., and Vondracek S.F. Prevention and treatment of nonpostmenopausal osteoporosis. Am J Health Syst Pharm 61 (2004) 2637-2654
78. Tamura Y., Okinaga H., and Takami H. Glucocorticoid-induced osteoporosis. Biomed Pharmacother 58 (2004) 500-504
79. Vestergaard P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med 95 (2004) 469-480
80. Dobnig H., Piswanger-Solkner J.C., Roth M., et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass and fracture risk. J Clin Endocrinol Metab 91 (2006) 3355-3363
81. Bischoff H.A., Stahelin H.B., Dick W., et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18 (2003) 343-351
82. Tangpricha V., Turner A., Spina C., Decastro S., Chen T.C., and Holick M.F. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr 80 (2004) 1645-1649
83. Holick M.F., and Vitamin. D deficiency: what a pain it is. Mayo Clin Proc 78 (2003) 1457-1459
84. Plotnikoff G.A., and Quigley J.M. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78 (2003) 1463-1470
85. Gaugris S., Heaney R.P., Boonen S., et al. D inadequacy among post-menopausal women: a systematic review. QJM 98 (2005) 667-676
86. Lips P., Hosking D., Lippuner K., et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260 (2006) 245-254
87. Sahota O., Krishnarajah G., Yaghi Y., et al. Association of vitamin D and latitude among postmenopausal women with osteoporosis living in nonequatorial regions. Abstracts of IOF World Congress on Osteoporosis. Toronto, June 2-6 (2006) S40 P165MO
88. Bruyere O., Malaise O., Neuprez A., Reginster J.-Y., and WHO Collaborating Center for Public Health. High prevalence of inadequate serum vitamin D levels in osteoporotic European postmenopausal women. Abstracts of IOF World Congress on Osteoporosis. Toronto, June 2-6 (2006) S33 P142SA
89. Lilliu H., Pamphile R., Chapuy M.C., Schulten J., Arlot M., and Meunier P.J. Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention. Maturitas 44 (2003) 299-305
90. Avenell A., Gillespie W.J., Gillespie L.D., and O'Connell D.L. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 3 (2005) CD000227
91. Porthouse J., Cockayne S., King C., et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. Br Med J 330 (2005) 1003-1005
92. Rapid responses to Porthouse et al., 2005. http://www.bmj.com/cgi/eletters/330/7498/1003#106178 [accessed 6 June 2006].
93. Grant A.M., Avenell A., Campbell M.K., et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D,RECORD): a randomised placebo-controlled trial. Lancet 365 (2005) 1621-1628
94. Jackson R.D., La Croix A.Z., Gass M., Wallace R.B., Robbins J., and Lewis C.E. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354 (2006) 669-683
95. Finkelstein J.S. Calcium plus Vitamin D for Postmenopausal Women-Bone Appetit?. N Engl J Med 354 (2006) 750-752
96. Chapuy M.C., Pamphile R., Paris E., et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 13 (2002) 257-264
97. Chapuy M.C., Chapuy P., Thomas J.L., Hazard M.C., and Meunier P.J. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients. Rev Rhum Engl Ed 63 (1996) 135-140
98. Bischoff-Ferrari H.A. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18 (2007) 401-407
99. Chalmers J., and Ho K.C. Geographical variations in senile osteoporosis. J Bone Joint Surg 52B (1970) 667-675
100. Aitken J.M. Relevance of osteoporosis in women with fractures of the femoral neck. Br Med J 288 (1984) 597-601
101. Hathcock J.N., Shao A., Vieth R., and Heaney R. Risk assessment for vitamin D. Am J Clin Nutrit 85 (2007) 6-18
102. WHI: a small but significant 1 percent higher hip bone density for women taking calcium combined with vitamin D. http://www.xagena.com/news/metabolismnews_net_news/f0bda020d2470f2e74990a07a607ebd9.html [accessed June 6, 2006].
103. Dhesi J.K., Jackson S.H., Bearne L.M., et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33 (2004) 589-595
104. Gallagher J.C. The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 89/90 (2004) 497-501
105. Delaney M.F. Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 194 2 Suppl (2006) S12-S23
106. Gass M., and Dawson-Hughes B. Preventing osteoporosis-related fractures: an overview. Am J Med 119 4 Suppl 1 (2006) S3-S11
107. Punnonen R., Salmi J., Tuimala R., Jarvinen M., and Pystynen P. Vitamin D deficiency in women with femoral neck fracture. Maturitas 8 (1986) 291-295
108. Pfeifer M., Begerow B., and Minne H.W. Vitamin D and muscle function. Osteoporos Int 13 (2002) 187-194
109. Demay M. Muscle: a nontraditional 1,25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent vitamin D receptor actions. Endocrinology 144 (2003) 5135-5137
110. Latham N.K., Anderson C.S., and Reid I.R. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc 51 (2003) 1219-1226
111. Heikinheimo R., Sievanen H., Jantti P., Maki-Jokela P.L., Rajala S., and Vuori I. Vitamin D treatment and bone mineral density in the aged. Maturitas 23 Suppl (1996) S77-S80
112. Nurmi I., Kaukonen J.P., Luthje P., et al. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland. Osteoporos Int 16 (2005) 2018-2024
113. Gallacher S.J., McQuillian C., Harkness M., Finlay F., Gallagher A.P., and Dixon T. Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin 21 (2005) 1355-1361
114. Moniz C., Dew T., and Dixon T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 21 (2005) 1891-1894
115. Dixon T., Mitchell P., Beringer T., et al. An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin 22 (2006) 405-415
116. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., et al. Effect of vitamin D on falls: a meta-analysis. JAMA 291 (2004) 1999-2006
117. Kai M.C., Anderson M., and Lau E.M. Exercise interventions: defusing the world's osteoporosis time bomb. Bull World Health Organ 81 (2003) 827-830
118. Krall E.A., Wehler C., Garcia R.I., Harris S.S., and Dawson-Hubhes B. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 111 (2001) 452-456
119. Bayly J.R., Hollands R.D., Riordan-Jones S.E., et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin 22 (2006) 131-137
120. Holick M.F., Siris E.S., Binkley N., et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90 (2005) 3215-3224
121. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate?. J Steroid Biochem Mol Biol 89/90 (2004) 611-614
122. Heckman G.A., Papaioannou A., Sebaldt R.J., et al. Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. BMC Musculoskeletal Disorders 3 (2002) 6
123. Omdahl J.L., Garry P.J., Hunsaker L.A., Hunt W.C., and Goodwin J.S. Nutritional status in a healthy elderly population; vitamin D. Am J Clin Nutr 36 (1982) 1225-1233
124. Seeman E., Wahner H.W., Offord K.P., Kumar R., Johnson W.J., and Riggs B.L. Differential effects of endocrine dysfunction on the axial and appendicular skeleton. J Clin Invest 69 (1982) 1302-1309
125. Vuillemin A., Guillemin F., Jouanny P., Denis G., and Jeandel C. Differential influence of physical activity on lumbar spine and femoral neck bone mineral density in the elderly population. J Gerontol A Biol Sci Med Sci 56 (2001) B248-B253
126. Robson R., Kendler D., Handel M., et al. Effect of once-weekly alendronate 70 mg and vitamin D3 2800 IU on fractional calcium absorption in postmenopausal osteoporotic women: a 4 week, double-blind, randomised, controlled multi-center clinical trial. Calcif Tissue Int 78 Suppl 1 (2006) 163 poster P482
127. Ones K., and Schacht E. Superiority of a combined treatment of alfacalcidol and alendronate compared to the monotherapies in postmenopausal osteoporosis. Calcif Tissue Int 78 Suppl 1 (2006) S151 poster P437
128. 3 receptors and activities in muscle. J Biol Chem 260 (1985) 8882-8891
129. Schott G., and Wills M. Muscle weakness in osteomalacia. Lancet 2 (1976) 626-629
130. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 7 (1986) 434-438
131. Pfeifer M., Begerow B., Minne H.W., et al. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109 (2001) 87-92
132. Sambrook P.N., Chen J.S., March L.M., et al. Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. J Clin Endocrinol Metab 89 (2004) 1572-1576
133. Bischoff-Ferrari H.A., Borchers M., Gudat F., Durmuller U., Stahelin H.B., and Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19 (2004) 265-269
134. Dhesi J.K., Bearne L.M., Moniz C., et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 17 (2002) 891-897
135. Janssen H.C., Samson M.M., and Verhaar H.J. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 75 (2002) 611-615
136. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥60 years. Am J Clin Nutr 80 (2004) 752-758
137. Snijder M.B., van Schoor N.M., Pluijm S.M., van Dam R.M., Visser M., and Lips P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91 (2006) 2980-2985
138. Faulkner K.A., Cauley J.A., Zmuda J.M., et al. Higher 1,25-dihydroxyvitamin D(3) concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 17 (2006) 1318-1328
139. Bischoff-Ferrari H.A., Orav E.J., and Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women A 3-year randomized Controlled Trial. Arch Intern Med 166 (2006) 424-430
140. Bischoff-Ferrari H.A., Conzelmann M., Stahelin H.B., et al. Is fall prevention by vitamin D mediated by a change in postural or dynamic balance?. Osteoporos Int 17 (2006) 656-663
141. Campion G.V., Delmas P.D., and Dieppe P.A. Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease. Br J Rheumatol 28 (1989) 393-398
142. Sowers M., Lachance L., Jamadar D., Hochberg M.C., Hollis B., Crutchfield M., et al. The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum 42 (1999) 483-489
143. Radin E.L., and Rose R.M. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Related Res 213 (1986) 34-40
144. Hannan M.T., Anderson J.J., Zhang Y., Levy D., and Felson D.T. Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. Arthritis Rheum 36 (1993) 1671-1680
145. Glowacki J., Hurwitz S., Thornhill T.S., Kelly M., and LeBoff M.S. Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty. J Bone Joint Surg Am 85-A (2003) 2371-2377
146. Hochberg M.C., Lethbridge-Cejku M., and Tobin J.D. Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging. Osteoarthritis Cartilage 12 Suppl A (2004) S45-S48
147. Sandini L., Arokoski J.P., Jurvelin J.S., and Kroger H. Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis. J Rheumatol 32 (2005) 1951-1957
148. Hunter D.J., Hart D., Snieder H., Bettica P., Swaminathan R., and Spector T.D. Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology (Oxford) 42 (2003) 1311-1316
149. Bischoff-Ferrari H.A., Zhang Y., Kiel D.P., and Felson D.T. Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis. Arthritis Rheum 53 (2005) 821-826
150. Lehmann H.J., Mouritzen U., Christgau S., Cloos P.A., and Christiansen C. Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 61 (2002) 530-533
151. Christgau S., Tanko L.B., Cloos P.A., et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause 11 (2004) 508-518
152. Bagger Y.Z., Tanko L.B., Alexandersen P., et al. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone 37 (2005) 425-430
153. Alexandersen P., Karsdal M.A., Qvist P., Reginster J.Y., and Christiansen C. Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone 40 (2007) 218-222